
Fluoxetine
CAS No. 54910-89-3
Fluoxetine( —— )
Catalog No. M14982 CAS No. 54910-89-3
Fluoxetine(LY110140) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI)class.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 34 | In Stock |
![]() ![]() |
25MG | 45 | In Stock |
![]() ![]() |
50MG | 51 | In Stock |
![]() ![]() |
100MG | 67 | In Stock |
![]() ![]() |
200MG | 121 | In Stock |
![]() ![]() |
500MG | 203 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameFluoxetine
-
NoteResearch use only, not for human use.
-
Brief DescriptionFluoxetine(LY110140) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI)class.
-
DescriptionFluoxetine(LY110140) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI)class. (In Vitro):Fluoxetine blocks the downregulation of cell proliferation resulting from inescapable shock (IS) of hippocampal cell. Fluoxetine increases the number of newborn cells in the dentate gyrus of the hippocampus of adult rat. Fluoxetine also increases the number of proliferating cells in the prelimbic cortex. Fluoxetine accelerates the maturation of immature neurons. Fluoxetine enhances neurogenesis-dependent long-term potentiation (LTP) in the dentate gyrus. Fluoxetine, but not citalopram, fluvoxamine, paroxetine and sertraline, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Fluoxetine produces robust and sustained increases in extracellular concentrations of norepinephrine and dopamine after acute systemic administration. (In Vivo):Fluoxetine treatment also reverses the deficit in escape latency observed in animals exposed to inescapable shock in adult male Sprague-Dawley rats. Fluoxetine (5 mg/kg) alone increases cell proliferation in the dentate gyrus. Coadministration (fluoxetine 5 mg/kg + olanzapine) also significantly increases the number of BrdU-positive cells compared with the control group. Fluoxetine combined with Olanzapine produces robust, sustained increases of extracellular levels of dopamine ([DA](ex)) and norepinephrine ([NE](ex)) up to 361% and 272% of the baseline, respectively, which are significantly greater than either drug alone.
-
In VitroFluoxetine blocks the downregulation of cell proliferation resulting from inescapable shock (IS) of hippocampal cell.?Fluoxetine increases the number of newborn cells in the dentate gyrus of the hippocampus of adult rat. Fluoxetine also increases the number of proliferating cells in the prelimbic cortex.Fluoxetine accelerates the maturation of immature neurons. Fluoxetine enhances neurogenesis-dependent long-term potentiation (LTP) in the dentate gyrus.Fluoxetine, but not citalopram, fluvoxamine, paroxetine and sertraline, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Fluoxetine produces robust and sustained increases in extracellular concentrations of norepinephrine and dopamine after acute systemic administration.
-
In VivoFluoxetine treatment also reverses the deficit in escape latency observed in animals exposed to inescapable shock in adult male Sprague-Dawley rats. Fluoxetine (5 mg/kg) alone increases cell proliferation in the dentate gyrus. Coadministration (fluoxetine 5 mg/kg + olanzapine) also significantly increases the number of BrdU-positive cells compared with the control group. Fluoxetine combined with Olanzapine produces robust, sustained increases of extracellular levels of dopamine ([DA](ex)) and norepinephrine ([NE](ex)) up to 361% and 272% of the baseline, respectively, which are significantly greater than either drug alone.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorSert (Sodium-dependent)| MRP1
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number54910-89-3
-
Formula Weight309.33
-
Molecular FormulaC17H18F3NO
-
Purity>98% (HPLC)
-
SolubilityWater: 50 mg/mL
-
SMILESCNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Richman A, et al. Epilepsy Res. 2007 Apr; 74(1):19-27.
molnova catalog



related products
-
Mesoridazine Besylat...
Mesoridazine (Serentil) is a piperidine neuroleptic drug belonging to the class of drugs called phenothiazines, used in the treatment of schizophrenia.
-
SB 258585 hydrochlor...
SB-258585 is a potent, selective and orally active 5-HT6 receptor antagonist with Ki of 8.9 nM.
-
5-Methyltryptamine h...
5-Methyltryptamine hydrochloride is a high-affinity 5-HT1C receptor ligand and a partial agonist of 5-HT.